About
Erasca Inc (NASDAQ:ERAS) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 12 2026
Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results
Mar 10 2026
Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau
Mar 5 2026
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat
Feb 24 2026
Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001
Feb 5 2026
Erasca to Present at Upcoming Conferences in February
Financials
Revenue
$0
Market Cap
$5.32 B
EPS
-0.44
Google Übersetzer